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ABSTRACT
Squamous cell carcinoma of the scrotum (SCCS) is rare, particularly in West Africa. It usually 
affects males older than 60 years. Although it was the first cancer to be linked to environmental 
factors, the mechanism of action of these risk factors is still not completely understood. We report 
on 4 men who presented with SCCS at our centre during a 20-month period. Three patients were 
relatively younger (mean age 43 years) and tested positive for human immunodeficiency virus 
(HIV) infection. They had no history of exposure to any known risk factor for SCCS. Thus, it 
seems that SCCS may occur in younger men who have HIV infection.
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INTRODUCTION                                                    
Malignant tumors of the scrotum are rare. 
Squamous cell carcinoma is the commonest 
malignant disorder of the scrotum. It was 
the first cancer to be directly linked to 
a specific occupation1. 
Squamous cell carcinoma of the scrotum 
(SCCS) is exceptionally rare in blacks. After 
the first report by Pott, less than 10 cases 
have been reported in black Americans2. 
Predisposing factors include exposure 
to chimney soot, industrial dyes (textile 
workers), poor hygiene, psoralens and 
ultraviolet radiation3. The human papilloma 
virus (HPV) has also been suggested to be 
an etiological factor. Buschke-Löwenstein 
tumor, a precancerous condition of the 
scrotum, has been associated with HPV 
subtypes 6 and 11. 
To our knowledge the occurrence of 
SCCS in patients infected with the human 
immunodeficiency virus (HIV) has not 
been reported previously. Although a report 
from Lagos University Teaching Hospital 
anecdotally described a case of fungating 
SCCS in an HIV-infected Nigerian, proposing 
the possible association, in our center SCCS 
is extremely rare, with an average of one case 
every 5 years4-5. However, in the 2-year period 
(2006–2007) we encountered four cases in 
Nigerian men, who are described here.
PATIENTS AND METHODS                                     
Patient 1:
A 39 year old clerk presented with a 9 
month history of chronic ulcer involving 
the left hemiscrotum. There was associated 
weight loss and painful inguinal swelling. 
He had no history of exposure to any of the 
known etiological factors for SCCS. The 
patient claimed to be happily married, but 
had a history of multiple sexual partners. 
Examination revealed a fungating mass 
of about 5 x 9 x 3 cm involving the left 
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Examination revealed an ulcer measuring 
about 7 x 10 cm with fungating edges invol-
ving the left hemiscrotum and extending to 
the root of the penis and inguinal region. The 
left inguinal lymph nodes were enlarged.
Abdominal and pelvic CT scan and 
chest X-ray were normal, but the Hb (done 
after an episode of major hemorrhage) 
was 8 gm/dl. Screening for HIV-I was 
positive and was confirmed by the Western 
blot method. Histopathology of biopsies 
from the ulcer edge revealed a well 
differentiated SCC.
The patient underwent left hemiscrotec-
tomy and left inguinal lymph node dissection 
within 10 days of presentation. Postoperative 
recovery was uneventful. Histopathological 
examination of the lymph nodes was negative 
for malignant cells. The patient was referred 
to a hematologist and started ART 2 weeks 
after surgery. Pre-therapy CD+4 count was 
148 cells/μl and viral load was 43,270 cpm. 
Twenty-eight months postoperatively, the pa-
tient was compliant with ART. Currently, he 
has clinically improved without evidence of 
tumor recurrence. 
Patient 3:
 A 55 year old civil servant presented with 
an 18 month history of right inguinoscrotal 
swelling. It had started as a pimple on the 
upper part of the right scrotum, which had 
ulcerated and continued to increase in size. 
The lesion bled intermittently. There was 
associated right pedal edema, weight loss and 
severe low back pain. The patient had worked 
as a driver with the Ministry of Transport 
for about 25 years, where he had occasional 
physical contact with different petroleum 
products, especially petrol, engine oil and 
exhaust soot.  
The patient looked ill. Scrotal examination 
revealed a huge fungating inguinoscrotal mass 
about 20 x 20 cm, fixed to the underlying 
structures and perineum, with gross edema 
of the right lower limb and bilateral  matted 
inguinal lymph nodes. Biopsy of the mass 
confirmed a diagnosis of a well differentiated 
hemiscrotum. The inguinal lymph nodes 
were enlarged and fixed. Histopathological 
examination of a biopsy taken from the scrotal 
ulcer revealed moderately differentiated 
non-keratinizing SCC. Chest X-ray was 
normal. The patient could not afford CT 
scan for further staging. Serological testing 
for HIV-1 infection using the Western blot 
technique was positive.
He was referred to the HIV clinic 
where further investigations for acquired 
immunodeficiency syndrome (AIDS) 
were carried out. CD4+ T–lymphocyte 
count was 238/μl. Viral load was 822,993 
(5.92 log 10) RNA copies per milliliter (RNA 
cpm) of plasma. Haemoglobin was 10.8 gm/
dl and the blood glucose was normal. 
Triple antiretroviral therapy (ART) with 
stavudine, lamivudine and nevirapine was 
started. The treatment led to an increased 
CD4+ count of 302/μl and reduced viral 
load with a 2-log reduction to 3,723 RNA 
cpm after 4 week..  However, there was no 
significant improvement in the patient’s 
general condition. Moreover, he developed 
transfusion dependant anaemia.
The scrotal tumor was examined again 
after about 2 months and was found to be 
inoperable due to extensive local invasion 
of the left testis, pubic bone, perineum and 
inguinal region. The patient received palliative 
radiotherapy but his condition gradually 
deteriorated and he died five months after 
presentation. 
Patient 2:
A 47-year old senior military officer pre-
sented with a one year history of a chro-
nic, gradually enlarging ulcer involving the 
left hemiscrotum. Over the preceding few 
months there had been multiple episodes of 
bleeding from the ulcer. There was no his-
tory of exposure to any of the recognized 
etiological factors for SCCS.  The patient 
denied a history of weight loss, diarrhea or 
any of the known symptoms of AIDS. He 
was married, but had a history of multiple 
sexual partners.
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SCC. Serological tests for HIV-I and II 
were negative. 
The tumor was inoperable and the 
patient was referred for radiotherapy and 
chemotherapy. However, his condition 
deteriorated and he eventually died nearly 3 
months after presentation.
Patient 4:
A 43year old school teacher and part-
time clergyman presented with a nine month 
history of a right hemiscrotal ulcer that was 
gradually increasing in size. There were no 
systemic symptoms. The patient denied a 
history of multiple sexual partners.
Local examination revealed an 8 x 6 cm 
ulcer of the right hemiscrotum with everted 
edges. The right inguinal lymph nodes 
were palpably enlarged. Biopsy from the 
ulcer confirmed a well differentiated SCC. 
Serological testing was positive for HIV-1. 
Abdominal and pelvic ultrasonography were 
negative for metastases. The patient was 
scheduled for surgical excision and referred 
to the HIV clinic and was then lost for follow 
up before surgical intervention.
 DISCUSSION                                                             
SCCS is extremely rare in Nigeria. In an 
earlier series reported from our center, only 4 
cases were seen in 20 years (1979 to 1998). 
Thus, the incidence was about 1/300,000 new 
male hospital attendances. All the patients 
had long-term exposure to known etiological 
factors for SCCS. None of the patients was 
younger than 50 years; their mean age was 
55.8 years (range 52.2 – 59 years). Two 
of the patients were tested for HIV and 
were negative, whereas 2 were not tested. 
Two patients had surgical excision while 2 
were unfit for surgery and were referred to 
radio- and chemotherapy. All 4 patients died 
within 2 years.
The present series of 4 patients were seen 
within only 2 years. The incidence is about 
1/55,000 new male hospital attendances 
at the center. Three of the 4 patients were 
HIV-positive and they were younger 
(mean age 43 years). They had no known 
predisposing factors for SCCS. Two of the 
lesions were on the left and one on the right. 
Two were ulcerative and one was fungating. 
The 4th patient (HIV negative) was 55 years 
old and had a known predisposing factor. 
The tumor was fungating and was on the 
right side.
Although the number of cases is very 
small, it should be noted that the HIV 
prevalence in our environment is about 4.4% 
(previously 5.8%)6. Therefore, the finding 
that 3 of 4 of the patients were HIV-positive 
indicates that HIV infection may contribute to 
the occurrence of SCCS in younger patients.
Malignancies associated with HIV 
infection include SCC at different sites, 
malignant melanoma, lymphoma and Kaposi 
sarcoma7. To our knowledge the association 
of HIV/AIDS with SCCS has not been 
previously reported. This is surprising, 
because  65-91% of AIDS patients present 
with visible cutaneous or mucosal lesions, 
while almost 50% develop cancer8-11.  
Although the mechanism of AIDS asso-
ciated malignancy is not fully understood, 
most authors believe that depression of the 
immune system is the major cause12. The des-
truction of CD4-helper cells, which help in 
activating natural killer (NK) cells, may be 
the main factor. NK cells are known for their 
capability to destroy tumor cells. Impairing 
function of the NK cells invariably leads 
to impaired resistance to tumor growth and 
spread. Brunner et al3 documented the asso-
ciation of scrotal cancer with HPV type 18. 
HIV infection may be associated with HPV 
related anogenital neoplasms. The risk of all 
HPV-associated cancers and in situ precursor 
lesions in both men and women is increased 
with all HIV exposure categories13.
HPV-associated oncogenesis results from 
up-regulated expression of viral encoded 
transforming proteins from HPV16 and 18, 
particularly E6 and E713-14. E6 appears to 
bind cellular tumor suppressor protein p53 
leading to its rapid degradation, which results 
in chromosome instability, DNA mutations 
52
SCC OF THE SCROTUM IN HIV POSITIVE PATIENTS
and aneuploidy, while E7 phosphorylates 
the PRB retinoblastoma protein leading to 
the release of transcription factor E2f that 
activates mitosis10. These events result in 
up-regulated cell cycle progression, deficient 
DNA repair and eventually malignant 
transformation13-14. HIV infection may 
predispose affected patients to rapid 
development of SCC from the pre- existing 
lesions13-14.
Unlike the three HIV-positive patients 
described here, SCCS is most frequent in the 
6th  and 7th  decades. Most patients have had 
long-term exposure to risk factors and there 
is usually a latent period of 10 to 25 years 
before cancer develops. Apart from their age 
and lack of exposure to known predisposing 
factors, the clinical presentation in the three 
patients described here was consistent with 
the literature on SCCS. All presented 8-12 
months after the onset of symptoms. The 
tumors started as nodular lesions which later 
ulcerated.
Only one patient underwent surgical exci-
sion. He was treated with hemiscrotectomy, 
ipsilateral inguinal lymphadenectomy (lym-
ph node negative for malignant cells) and 
ART and 2 years post-treatment the patient 
had no evidence of local recurrence. It will 
be useful to know the actual incidence and 
characteristics of SCCS in HIV-positive pa-
tients and, conversely, the incidence of HIV 
in SCCS patients. More information may be 
available in future if physicians managing 
HIV-positive patients have a high index of 
suspicion and carefully examine the scrotum 
of their patients.
In conclusion, SCCS is rare condition that 
occurs in older males. In association with 
HIV infection; it seems to be more common 
in younger men.                         
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Editorial Comment: 
Acquired immunodeficiency disease (AIDS) is known to be associated with a significantly high rate 
of genitourinary neoplasm, possibly due to the destruction of cellular immunity, oncogenic DNA 
viruses and production of HIV-1 protein Tat.   The authors reported an increased incidence of scrotal 
squamous cell carcinoma (SCC) in AIDS patients occurring at a younger age, although none of the 
three patients reported had been exposed to any of the known environmental or occupational risk 
factors that predispose to scrotal SCC. This clue may indicate changes in the biological behavior 
of that rare oncological entity in AIDS patients. To elucidate this point, it is necessary to look 
for coincidental infection with human papilloma virus (HPV) in such patients. The possibility of 
synergism between HIV and HPV in the oncogenesis of scrotal SCC should also be considered. 
To establish whether there is synchronization between the two viruses, or one precedes the other 
inducing acceleration of malignant transformation requires further study. 
While appropriate staging of scrotal SCC should be done diligently, the authors examined the 
patients clinically and performed only US and/or CT, which are not very specific and of limited 
value. We suggest the assessment of the pelvic lymph node status, as it is essential for proper 
staging and proper treatment, whereas abdominal and pelvic CT and chest X-ray should be done 
in every case. Moreover, the testes and spermatic cord should be investigated by MRI for tumor 
invasion. In addition, dynamic scintigraphy may be useful for studying sentinel lymph nodes using 
Tc99m and patent blue dye. 
Finally, adequate information on this oncological entity may become clearer with further experience 
and larger numbers of patients. 
Prof. Adel Elbakry
Department of Urology, Suez Canal University
Authors’ Reply:
We do agree with the points raised in the editorial. The major limitations faced in the management 
of these patients (who were entirely responsible for the cost of their health care); included poverty 
and very late presentation, except in patient number 2, the senior military officer. As a result, some 
investigations had to be excluded. We have no other response. 
Dr. Habeeb Tijani
